首页> 外文OA文献 >Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

【2h】

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

机译：28-59岁的健康成人中SARS-COV-2灭活疫苗的免疫原性和安全性：随机，双盲和安慰剂控制第2期临床试验报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yanjun Zhang; Gang Zeng; Hongxing Pan; Changgui Li; Biao Kan; Yaling Hu; Haiyan Mao; Qianqian Xin; Kai Chu; Weixiao Han; Zhen Chen; Rong Tang; Weidong Yin; Xin Chen; Xuejie Gong; Chuan Qin; Yuansheng Hu; Xiaoyong Liu; Guoliang Cui; Congbing Jiang; Hengming Zhang; Jingxin Li; Minnan Yang; Xiaojuan Lian; Yan Song; Jinxing Lu; Xiangxi Wang; Miao Xu; Qiang Gao; Fengcai Zhu;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults:randomized,double-blind,and placebo-controlled phase 1 and phase 2 clinical trials [J] . Hong-Xing Pan, Jing-Xin Li, Dan-Dan Zhu, 中华医学杂志（英文版） . 2021,第011期

机译：严重急性呼吸综合征冠状病毒2灭活疫苗在健康成人中的免疫原性和安全性：随机，双盲和安慰剂控制阶段1和第2期临床试验
2. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged = 18 years: A phase III, randomized trial [J] . Tinoco Juan Carlos, Pavia-Ruz Noris, Cruz-Valdez Aurelio, Vaccine . 2014,第13期

机译：≥18岁健康成年人体内灭活的四价流感疫苗候选物与灭活的三价流感疫苗的免疫原性，反应原性和安全性：III期随机试验
3. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China [J] . Wang Shi-Yuan, Liu Shu-Zhen, Chu Kai, Expert review of vaccines . 2017,第7a12期

机译：在参与者> / = 3岁以下的灭活四价流感疫苗候选与灭活三价流感疫苗的免疫原性和安全性：中国的双盲，随机，平行控股第三阶段临床试验
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Effect of Infliximab on General Cognition in a Population of Depressed Individuals with Bipolar Disorder Type I/II [D] . Pan, Zihang. 2018

机译：一项随机，双盲，安慰剂对照的临床试验，评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
6. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized double-blind placebo-controlled phase 1/2 trial [O] . Wanshen Guo, Kai Duan, Yuntao Zhang, 2021

机译：在18岁或以上的健康成年人中灭活的SARS-COV-2疫苗的安全性和免疫原性：随机双盲安慰剂控制1/2次试验
7. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial [O] . Zhiwei Wu, Yaling Hu, Miao Xu, 2021

机译：60岁及以上健康成人的灭活SARS-COV-2疫苗（Coronavac）的安全性，耐受性和免疫原性：随机，双盲，安慰剂控制，第1/2期临床试验
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

著录项

相似文献

相关主题

期刊订阅